|
1) The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997; 89: 3909-18
|
|
|
|
2) Cairo MS, Sposto R, Perkins SL, et al. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br J Haematol. 2003; 120: 660-70
|
|
|
|
|
3) Jaffe ES, Harris NL, Stein H, et al. editors. In: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARCPress; 2001
|
|
|
|
|
|
4) Duggan DJ, Bittner M, Chen Y, et al. Expression profiling using cDNA microarrays. Nat Genet. 1999; 21: 10-4
|
|
|
|
|
|
5) Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006; 354: 2419-30
|
|
|
|
|
|
6) Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med. 2006; 354: 2431-42
|
|
|
|
|
|
7) Yamashita Y, Ohashi J, Hirai Y, et al. Gene expression profiles of CD133-positive fractions predict the survival of individuals with acute myeloid leukemia. Cancer Genomics & Proteomics. 2006; 3: 169-82
|
|
|
|
|
|
8) Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004; 350: 1617-28
|
|
|
|
|
|
9) Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346: 1937-47
|
|
|
|
|
|
10) Zhan F, Hardin J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002; 99: 1745-57
|
|
|
|
|
|
11) Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 2002; 8: 816-24
|
|
|
|
|
|
12) van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415: 530-6
|
|
|
|
|
|
13) Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001; 412: 822-6
|
|
|
|
|